Eam Investors, LLC Champions Oncology, Inc. Transaction History

Eam Investors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$10.61 - $13.75 $1.06 Million - $1.37 Million	-99,763 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$8.39 - $13.27 $837,011 - $1.32 Million	99,763 New	99,763 $1.08 Million
Q2 2019 Aug 14, 2019	SELL	$7.51 - $10.12 $352,158 - $474,547	-46,892 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$7.89 - $12.23 $1.18 Million - $1.83 Million	-149,479 Reduced 76.12%	46,892 $459,000
Q4 2018 Feb 13, 2019	BUY	$7.29 - $15.27 $119,541 - $250,397	16,398 Added 9.11%	196,371 $1.53 Million
Q3 2018 Nov 08, 2018	BUY	$5.82 - $17.47 $1.05 Million - $3.14 Million	179,973 New	179,973 $3.14 Million

5.81M

3.3K

6.1K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $53.7M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.